Medroxyprogesterone is used to treat abnormal menstruation (periods) or irregular vaginal bleeding
Risk Summary: This drug is not indicated for use in females of reproductive potential; there appears to be little or no increased risk of birth defects in women who
For oral dosage form (tablets): For prevention endometrial hyperplasia: Adults—At first, 5 milligrams (mg) per day
The Depo-Provera® shot works by impacting ovulation — the part of the reproductive cycle when an egg is released from a woman’s ovary — and thickening your cervical mucus
Keep all drugs
Peak milk levels occurred at varying times between days 8
The World Health Organization (WHO) and the UN’s Special Programme on Human Reproduction (HRP) have launched a new series on maternal and newborn
Was this page helpful? 96% effective
Provera is available in three dosages: 2
Although Depo-Provera CI can be passed to the nursing baby in the breast milk, no harmful effects on babies have been found
drugs (prescription or OTC, natural products, vitamins) and health problems
Your doctor will tell you what day of your cycle to start taking it Based on the studies reviewed, it is not known if promethazine can cause other pregnancy-related problems, such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces at birth)
However, dose is usually not more than 10 mg per day
It is a birth control method that works by stopping a woman's egg from fully developing each month
With typical use, 6 in 100 women get pregnant during the first year of using the injection
Skyla: provides up to 3 years of protection As Olivia experienced, the signs of pregnancy after Depo are the same signs of pregnancy you could expect if you were not taking birth control, including: Missed period
Progestins and estrogens are the two major classes of female hormones
Animal studies carried out on mice, rats and rabbits have shown dose-related teratogenicity and
5) Liver Function: Discontinue Depo-Provera CI if jaundice or disturbances of liver function develop
8 kg women who completed 1 year of therapy with Depo-Provera gained an average of 2
Although some reports have suggested that oral contraceptive hormones may cause a variety of congenital malformations, recent studies (including a meta-analysis of prospective studies) have suggested that an association between oral contraceptive use Self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) should be made available as an additional approach to deliver injectable contraception
weight gain; bruising or swelling of your veins; tiredness, trouble sleeping; or